Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Chung Ko

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The European Respiratory Journal|August 26, 2017
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in TaiwanMeng-Rui Lee, Cheng-Maw Ho, Chih-Hsin Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and MetaanalysisMeng-Rui Lee, Ya-Ping Huang, Yu-Ting Kuo, et al.
Toxicology|February 24, 2019
Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Tzu-Ying Chen, et al.
Frontiers in Medicine|June 21, 2021
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical VentilationLi-Ta Keng, Sheng-Kai Liang, Chi-Ping Tseng, et al.
Frontiers in Oncology|January 25, 2021
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry CohortSheng-Kai Liang, Li-Ta Keng, Chia-Hao Chang, et al.
Infectious Diseases and Therapy|February 11, 2023
Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature ReviewChia-Hao Chang, Lih-Yu Chang, Jen-Chung Ko, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2013
Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cellsJen-Chung Ko, Yu-Ching Huang, Huang-Jen Chen, et al.
Chemotherapy|August 11, 2024
Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ching-Hsiu Huang, et al.
Journal of Cancer|August 17, 2019
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with <i>EGFR</i>-mutated non-small-cell lung cancer - A multicenter prospective SMILE studyYu-Feng Wei, Wen-Tsung Huang, Tu-Chen Liu, et al.
Biochemical Pharmacology|July 28, 2015
Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cellsJen-Chung Ko, Tai-Jing Wang, Po-Yuan Chang, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The European Respiratory Journal|August 26, 2017
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in TaiwanMeng-Rui Lee, Cheng-Maw Ho, Chih-Hsin Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and MetaanalysisMeng-Rui Lee, Ya-Ping Huang, Yu-Ting Kuo, et al.
Toxicology|February 24, 2019
Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Tzu-Ying Chen, et al.
Frontiers in Medicine|June 21, 2021
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical VentilationLi-Ta Keng, Sheng-Kai Liang, Chi-Ping Tseng, et al.
Frontiers in Oncology|January 25, 2021
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry CohortSheng-Kai Liang, Li-Ta Keng, Chia-Hao Chang, et al.
Infectious Diseases and Therapy|February 11, 2023
Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature ReviewChia-Hao Chang, Lih-Yu Chang, Jen-Chung Ko, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2013
Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cellsJen-Chung Ko, Yu-Ching Huang, Huang-Jen Chen, et al.
Chemotherapy|August 11, 2024
Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ching-Hsiu Huang, et al.
Journal of Cancer|August 17, 2019
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with <i>EGFR</i>-mutated non-small-cell lung cancer - A multicenter prospective SMILE studyYu-Feng Wei, Wen-Tsung Huang, Tu-Chen Liu, et al.
Biochemical Pharmacology|July 28, 2015
Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cellsJen-Chung Ko, Tai-Jing Wang, Po-Yuan Chang, et al.
Pageof 6